Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Cash & Equivalents: 2019-2020

Historic Cash & Equivalents for Bright Minds Biosciences (DRUG) over the last 2 years, with Sep 2020 value amounting to $595,127.

  • Bright Minds Biosciences' Cash & Equivalents rose 36265.45% to $22.0 million in Q2 2021 from the same period last year, while for Jun 2021 it was $22.0 million, marking a year-over-year increase of 36265.45%. This contributed to the annual value of $595,127 for FY2020, which is 882.00% up from last year.
  • According to the latest figures from FY2021, Bright Minds Biosciences' Revenue - Interest and Investment Income is $15.4 million, which was up 2,729.35% from $542,576 recorded in FY2020.
  • Bright Minds Biosciences' 5-year Cash & Equivalents high stood at $595,127 for FY2020, and its period low was $60,603 during FY2019.
  • For the 3-year period, Bright Minds Biosciences' Revenue - Interest and Investment Income averaged around $5.3 million, with its median value being $542,576 (2020).
  • Data for Bright Minds Biosciences' Revenue - Interest and Investment Income shows a peak YoY spiked of 2,729.35% (in 2021) over the last 5 years.
  • Over the past 2 years, Bright Minds Biosciences' Cash & Equivalents (Yearly) stood at $60,603 in 2019, then soared by 882.00% to $595,127 in 2020.